These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 10555221)

  • 1. [Genetic analysis of familial prostatic cancer: localization of a gene predisposing to prostatic cancer (PCaP) on chromosome 1q 42.2-43].
    Valeri A; Drelon E; Paiss T; Vogel W; de Petriconi R; Hautmann R; Fournier G; Mangin P; Berthon P; Cussenot O
    Prog Urol; 1999 Sep; 9(4):680-8. PubMed ID: 10555221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
    Cancel-Tassin G; Latil A; Valéri A; Mangin P; Fournier G; Berthon P; Cussenot O
    Eur J Hum Genet; 2001 Feb; 9(2):135-42. PubMed ID: 11313747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suggestive linkage of familial primary cutaneous amyloidosis to a locus on chromosome 1q23.
    Lin MW; Lee DD; Lin CH; Huang CY; Wong CK; Chang YT; Liu HN; Hsiao KJ; Tsai SF
    Br J Dermatol; 2005 Jan; 152(1):29-36. PubMed ID: 15656797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic, epidemiologic and clinical study of familial prostate cancer].
    Valéri A
    Bull Acad Natl Med; 2002; 186(4):779-88; discussion 788-91. PubMed ID: 12412374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiology of familial prostatic cancer: 4-year assessment of French studies].
    Valeri A; Drelon E; Azzouzi R; Delannoy A; Teillac P; Fournier G; Mangin P; Berthon P; Cussenot O
    Prog Urol; 1999 Sep; 9(4):672-9. PubMed ID: 10555220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium.
    Edwards S; Meitz J; Eles R; Evans C; Easton D; Hopper J; Giles G; Foulkes WD; Narod S; Simard J; Badzioch M; Mahle L;
    Prostate; 2003 Dec; 57(4):270-9. PubMed ID: 14601023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The PROGENE study, the French project of genetic analysis of familial prostatic cancer: recruitment and analysis].
    Valeri A; Berthon P; Fournier G; Buzzi JC; Briollais L; Meria P; Blanche H; Bellanne-Chantelot C; Teillac P; Demenais F; Mangin P; Cohen N; Le Duc A; Cussenot O
    Prog Urol; 1996 Apr; 6(2):226-35. PubMed ID: 8777415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of linkage to chromosome 1q42.2-43 in 131 prostate cancer families from the ACTANE consortium. Anglo, Canada, Texas, Australia, Norway, EU Biomed.
    Singh R;
    Br J Cancer; 2000 Dec; 83(12):1654-8. PubMed ID: 11104562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.
    Berthon P; Valeri A; Cohen-Akenine A; Drelon E; Paiss T; Wöhr G; Latil A; Millasseau P; Mellah I; Cohen N; Blanché H; Bellané-Chantelot C; Demenais F; Teillac P; Le Duc A; de Petriconi R; Hautmann R; Chumakov I; Bachner L; Maitland NJ; Lidereau R; Vogel W; Fournier G; Mangin P; Cussenot O
    Am J Hum Genet; 1998 Jun; 62(6):1416-24. PubMed ID: 9585607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Linkage analysis of susceptibility genes for familial schizophrenia on chromosome 1 in Chinese population].
    Cai G; Wu X; Li T; Collier DA; Liu X; Feng B; Deng H; Tong D; Li J; Ou J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Dec; 19(6):491-4. PubMed ID: 12476422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.
    Lange EM; Chen H; Brierley K; Perrone EE; Bock CH; Gillanders E; Ray ME; Cooney KA
    Clin Cancer Res; 1999 Dec; 5(12):4013-20. PubMed ID: 10632333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1.
    Grönberg H; Xu J; Smith JR; Carpten JD; Isaacs SD; Freije D; Bova GS; Danber JE; Bergh A; Walsh PC; Collins FS; Trent JM; Meyers DA; Isaacs WB
    Cancer Res; 1997 Nov; 57(21):4707-9. PubMed ID: 9354426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci.
    Goode EL; Stanford JL; Peters MA; Janer M; Gibbs M; Kolb S; Badzioch MD; Hood L; Ostrander EA; Jarvik GP
    Clin Cancer Res; 2001 Sep; 7(9):2739-49. PubMed ID: 11555587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
    Schleutker J; Matikainen M; Smith J; Koivisto P; Baffoe-Bonnie A; Kainu T; Gillanders E; Sankila R; Pukkala E; Carpten J; Stephan D; Tammela T; Brownstein M; Bailey-Wilson J; Trent J; Kallioniemi OP
    Clin Cancer Res; 2000 Dec; 6(12):4810-5. PubMed ID: 11156239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer.
    Johanneson B; Deutsch K; McIntosh L; Friedrichsen-Karyadi DM; Janer M; Kwon EM; Iwasaki L; Hood L; Ostrander EA; Stanford JL
    Prostate; 2007 May; 67(7):732-42. PubMed ID: 17372923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a prostate cancer susceptibility locus on the X chromosome.
    Xu J; Meyers D; Freije D; Isaacs S; Wiley K; Nusskern D; Ewing C; Wilkens E; Bujnovszky P; Bova GS; Walsh P; Isaacs W; Schleutker J; Matikainen M; Tammela T; Visakorpi T; Kallioniemi OP; Berry R; Schaid D; French A; McDonnell S; Schroeder J; Blute M; Thibodeau S; Grönberg H; Emanuelsson M; Damber JE; Bergh A; Jonsson BA; Smith J; Bailey-Wilson J; Carpten J; Stephan D; Gillanders E; Amundson I; Kainu T; Freas-Lutz D; Baffoe-Bonnie A; Van Aucken A; Sood R; Collins F; Brownstein M; Trent J
    Nat Genet; 1998 Oct; 20(2):175-9. PubMed ID: 9771711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.
    Cunningham JM; McDonnell SK; Marks A; Hebbring S; Anderson SA; Peterson BJ; Slager S; French A; Blute ML; Schaid DJ; Thibodeau SN;
    Prostate; 2003 Dec; 57(4):335-46. PubMed ID: 14601030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees.
    Christensen GB; Camp NJ; Farnham JM; Cannon-Albright LA
    Prostate; 2007 May; 67(6):605-13. PubMed ID: 17299800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease.
    Lee JH; Cheng R; Santana V; Williamson J; Lantigua R; Medrano M; Arriaga A; Stern Y; Tycko B; Rogaeva E; Wakutani Y; Kawarai T; St George-Hyslop P; Mayeux R
    Arch Neurol; 2006 Nov; 63(11):1591-8. PubMed ID: 17101828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26.
    Schleutker J; Baffoe-Bonnie AB; Gillanders E; Kainu T; Jones MP; Freas-Lutz D; Markey C; Gildea D; Riedesel E; Albertus J; Gibbs KD; Matikainen M; Koivisto PA; Tammela T; Bailey-Wilson JE; Trent JM; Kallioniemi OP
    Prostate; 2003 Dec; 57(4):280-9. PubMed ID: 14601024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.